CHA has submitted comments to the Center for Medicare & Medicaid Innovation in response to its anticipated Accelerating Clinical Evidence (ACE) model.
This content is restricted to members.
CHA has submitted comments to the Center for Medicare & Medicaid Innovation in response to its anticipated Accelerating Clinical Evidence (ACE) model.
This content is restricted to members.
